CEMI News and Press, Chembio Diagnostics Inc. From 03/20/20

Bellerophon Therapeutics (NASDAQ: BLPH ) +472% on FDA nod for emergency use of INOpulse for Covid-19. More news on: Bellerophon Therapeutics, Inc., Rand Capital, GenMark Diagnostics, Inc., Stocks on the move, Read more ...

HAUPPAUGE, N.Y., March 20, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostic company focused on infectious diseases, today reported that, in accordance with Nasdaq Listing Rule 5635(c)(4), it has granted a restricted stock unit a...

Thinly traded nano cap Chembio Diagnostics (NASDAQ: CEMI ) jumps  31%  premarket on the heels of a $4M order from a buyer in Brazil for its DPP COVID-19 IgM/IgG point-of-care blood test. More news on: Chembio Diagnostics, Inc., Healthcare stocks news, Stocks on the move, Re...

HAUPPAUGE, N.Y., March 20, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostic company focused on infectious diseases, today announced its receipt of a $4 million order from Bio-Manguinhos for the purchase of Chembio’s DPP C...

Aimed at ramping up testing capacity in the U.S., the FDA will now allow individual states to authorize the use of laboratory-developed tests by qualified in-state labs for the coronavirus causing the current outbreak. The labs do not have to engage with the FDA nor will they need to apply...

Certain coronavirus plays are the lone beneficiaries, as usual, during the U.S. market's turmoil related to COVID-19. More news on: NanoViricides, Inc., Alpha Pro Tech, Ltd., AIM ImmunoTech Inc., Healthcare stocks news, Stocks on the move, Read more ...

OPKO Health (NASDAQ: OPK ) +45%  as subsidiary BioReference Laboratories is now  accepting samples  for COVID-19.  More news on: OPKO Health, Inc., Liberty TripAdvisor Holdings, Inc., Norwegian Cruise Line Holdings Ltd., Stocks on the move, , Read more ...

Chembio Diagnostics ( CEMI ) Q4 results : More news on: Chembio Diagnostics, Inc., Healthcare stocks news, Stocks on the move, Earnings news and commentary, , Read more ...

Chembio Diagnostics, Inc. (CEMI) Q4 2019 Earnings Conference Call March 12, 2020, 04:30 PM ET Company Participants Lynn Lewis - Investor Relations Gail Page - Interim President & Chief Executive Officer Neil Goldman - Executive Vice President & Chief Financial Officer R...

HAUPPAGE, N.Y., March 12, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today announced the appointment of Richard Eberly as its President and Chief Executive Officer effective March 16, 2020. M...